That would be nice but I don't expect Cain or anyone else associated with NSPX saying anything or do I expect any news coming out until it is ready to be announced. The filing might even be boilerplate as it has been in the past. I doubt that after 13 years of research, multiple patents, clinical trial results, orphan drug designations, and ongoing studies that this minuscule market cap will be the outcome of the ticker.